» Articles » PMID: 20733065

Dynamic MicroRNA Expression Programs During Cardiac Differentiation of Human Embryonic Stem Cells: Role for MiR-499

Overview
Date 2010 Aug 25
PMID 20733065
Citations 98
Authors
Affiliations
Soon will be listed here.
Abstract

Background: MicroRNAs (miRNAs) are a newly discovered endogenous class of small, noncoding RNAs that play important posttranscriptional regulatory roles by targeting messenger RNAs for cleavage or translational repression. Human embryonic stem cells are known to express miRNAs that are often undetectable in adult organs, and a growing body of evidence has implicated miRNAs as important arbiters of heart development and disease.

Methods And Results: To better understand the transition between the human embryonic and cardiac "miRNA-omes," we report here the first miRNA profiling study of cardiomyocytes derived from human embryonic stem cells. Analyzing 711 unique miRNAs, we have identified several interesting miRNAs, including miR-1, -133, and -208, that have been previously reported to be involved in cardiac development and disease and that show surprising patterns of expression across our samples. We also identified novel miRNAs, such as miR-499, that are strongly associated with cardiac differentiation and that share many predicted targets with miR-208. Overexpression of miR-499 and -1 resulted in upregulation of important cardiac myosin heavy-chain genes in embryoid bodies; miR-499 overexpression also caused upregulation of the cardiac transcription factor MEF2C.

Conclusions: Taken together, our data give significant insight into the regulatory networks that govern human embryonic stem cell differentiation and highlight the ability of miRNAs to perturb, and even control, the genes that are involved in cardiac specification of human embryonic stem cells.

Citing Articles

High-throughput microRNA sequencing in the developing branchial arches suggests miR-92b-3p regulation of a cardiovascular gene network.

Goldsworthy S, Losa M, Bobola N, Griffiths-Jones S Front Genet. 2025; 16:1514925.

PMID: 40051700 PMC: 11882518. DOI: 10.3389/fgene.2025.1514925.


The molecular mechanisms of cardiac development and related diseases.

Li Y, Du J, Deng S, Liu B, Jing X, Yan Y Signal Transduct Target Ther. 2024; 9(1):368.

PMID: 39715759 PMC: 11666744. DOI: 10.1038/s41392-024-02069-8.


Integrated small RNA, mRNA and protein omics reveal a miRNA network orchestrating metabolic maturation of the developing human heart.

Aharon-Yariv A, Wang Y, Ahmed A, Delgado-Olguin P BMC Genomics. 2023; 24(1):709.

PMID: 37996818 PMC: 10668469. DOI: 10.1186/s12864-023-09801-8.


MicroRNAs in cardiovascular diseases.

Li H, Zhan J, Chen C, Wang D Med Rev (2021). 2023; 2(2):140-168.

PMID: 37724243 PMC: 10471109. DOI: 10.1515/mr-2021-0001.


Consequences of genetic variants in miRNA genes.

Machowska M, Galka-Marciniak P, Kozlowski P Comput Struct Biotechnol J. 2022; 20:6443-6457.

PMID: 36467588 PMC: 9708458. DOI: 10.1016/j.csbj.2022.11.036.


References
1.
Liang Y, Ridzon D, Wong L, Chen C . Characterization of microRNA expression profiles in normal human tissues. BMC Genomics. 2007; 8:166. PMC: 1904203. DOI: 10.1186/1471-2164-8-166. View

2.
Catalucci D, Gallo P, Condorelli G . MicroRNAs in cardiovascular biology and heart disease. Circ Cardiovasc Genet. 2009; 2(4):402-8. DOI: 10.1161/CIRCGENETICS.109.857425. View

3.
Zhao Y, Ransom J, Li A, Vedantham V, von Drehle M, Muth A . Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell. 2007; 129(2):303-17. DOI: 10.1016/j.cell.2007.03.030. View

4.
Van Rooij E, Sutherland L, Liu N, Williams A, McAnally J, Gerard R . A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A. 2006; 103(48):18255-60. PMC: 1838739. DOI: 10.1073/pnas.0608791103. View

5.
Gao X, Gulari E, Zhou X . In situ synthesis of oligonucleotide microarrays. Biopolymers. 2004; 73(5):579-96. DOI: 10.1002/bip.20005. View